These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 24550334)
1. Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration. Yapa SWS; Li J; Patel K; Wilson JW; Dooley MJ; George J; Clark D; Poole S; Williams E; Porter CJ; Nation RL; McIntosh MP Antimicrob Agents Chemother; 2014 May; 58(5):2570-9. PubMed ID: 24550334 [TBL] [Abstract][Full Text] [Related]
2. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model. Landersdorfer CB; Nguyen TH; Lieu LT; Nguyen G; Bischof RJ; Meeusen EN; Li J; Nation RL; McIntosh MP Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients. Boisson M; Grégoire N; Cormier M; Gobin P; Marchand S; Couet W; Mimoz O J Antimicrob Chemother; 2017 Sep; 72(9):2607-2612. PubMed ID: 28575278 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. Ratjen F; Rietschel E; Kasel D; Schwiertz R; Starke K; Beier H; van Koningsbruggen S; Grasemann H J Antimicrob Chemother; 2006 Feb; 57(2):306-11. PubMed ID: 16396919 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of colistin after nebulization or intravenous administration of colistin methanesulphonate (Colimycin®) to cystic fibrosis patients. Magréault S; Mankikian J; Marchand S; Diot P; Couet W; Flament T; Grégoire N J Cyst Fibros; 2020 May; 19(3):421-426. PubMed ID: 31501050 [TBL] [Abstract][Full Text] [Related]
6. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients. Boisson M; Jacobs M; Grégoire N; Gobin P; Marchand S; Couet W; Mimoz O Antimicrob Agents Chemother; 2014 Dec; 58(12):7331-9. PubMed ID: 25267660 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary and Systemic Pharmacokinetics of Colistin Following a Single Dose of Nebulized Colistimethate in Mechanically Ventilated Neonates. Nakwan N; Lertpichaluk P; Chokephaibulkit K; Villani P; Regazzi M; Imberti R Pediatr Infect Dis J; 2015 Sep; 34(9):961-3. PubMed ID: 26065861 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections. Yapa SWS; Li J; Porter CJ; Nation RL; Patel K; McIntosh MP Antimicrob Agents Chemother; 2013 Oct; 57(10):5087-95. PubMed ID: 23917323 [TBL] [Abstract][Full Text] [Related]
14. Systemic absorption of nasally administered tobramycin and colistin in patients with cystic fibrosis. Berkhout MC; van Velzen AJ; Touw DJ; de Kok BM; Fokkens WJ; Heijerman HG J Antimicrob Chemother; 2014 Nov; 69(11):3112-5. PubMed ID: 25016384 [TBL] [Abstract][Full Text] [Related]
15. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia. Benítez-Cano A; de Antonio-Cuscó M; Luque S; Sorlí L; Carazo J; Ramos I; Bermejo S; Campillo N; Horcajada JP; Samsó E; Grau S J Antimicrob Chemother; 2019 Nov; 74(11):3268-3273. PubMed ID: 31495877 [TBL] [Abstract][Full Text] [Related]
16. Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses. Marchand S; Lamarche I; Gobin P; Couet W J Antimicrob Chemother; 2010 Aug; 65(8):1753-8. PubMed ID: 20507861 [TBL] [Abstract][Full Text] [Related]
17. Comment on: pharmacokinetics of inhaled colistin in patients with cystic fibrosis. Li J; Nation RL J Antimicrob Chemother; 2006 Jul; 58(1):222-3; author reply 223. PubMed ID: 16641116 [No Abstract] [Full Text] [Related]
18. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis. Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats. Lin YW; Zhou QT; Hu Y; Onufrak NJ; Sun S; Wang J; Forrest A; Chan HK; Li J Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807905 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. Li J; Milne RW; Nation RL; Turnidge JD; Smeaton TC; Coulthard K J Antimicrob Chemother; 2004 May; 53(5):837-40. PubMed ID: 15044428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]